share_log
Breakings ·  Nov 14 20:00
BioXcel Therapeutics Q3 Operating Income USD -15.293 Million Vs. IBES Estimate USD -19.1 Million
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment